Legend Biotech (LEGN) Misses Q1 EPS by 16c
Tweet
Share
E-mailGet Alerts LEGN Hot Sheet
Join SI Premium – FREE
Legend Biotech (NASDAQ: LEGN) reported Q1 EPS of ($0.15), $0.16 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $305.1 million versus the consensus estimate of $305.88 million.
For earnings history and earnings-related data on Legend Biotech (LEGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rockstar Energy founder seeks CEO role at Celsius Holdings
- Artiva Biotherapeutics, Inc. (ARTV) Misses Q2 EPS by 63c
- Revelation Biosciences (REVB) Misses Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
